Effect of Vaccination with Carrier Protein on Response to Meningococcal C Conjugate Vaccines and Value of Different Immunoassays as Predictors of Protection

In order to plan for the wide-scale introduction of meningococcal C conjugate (MCC) vaccine for United Kingdom children up to 18 years old, phase II trials were undertaken to investigate whether there was any interaction between MCC vaccines conjugated to tetanus toxoid (TT) or a derivative of dipht...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Infect Immun
Principais autores:	Burrage, Moya, Robinson, Andrew, Borrow, Ray, Andrews, Nick, Southern, Joanna, Findlow, Jamie, Martin, Sarah, Thornton, Carol, Goldblatt, David, Corbel, Michael, Sesardic, Dorothea, Cartwight, Keith, Richmond, Peter, Miller, Elizabeth
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2002
Assuntos:	Microbial Immunity and Vaccines
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC128295/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12183540/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/IAI.70.9.4946-4954.2002
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!